8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)
Published . Updated .
Key takeaways
- 8-K - RHYTHM PHARMACEUTICALS filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
- Exposed: RYTM
- Market reaction: RYTM +19.9% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - RHYTHM PHARMACEUTICALS filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- RYTM Rhythm Pharmaceuticals+32.2% 6d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+23.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+8.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+4.4% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+4.3% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| RYTM | -1.45% | -0.46% | base | -7.76% | +12.35% | +12.37% | +19.95% |
| XLV | -2.95% | -0.31% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| XBI | +1.84% | +3.78% | base | +1.89% | +4.64% | -2.40% | +0.10% |
| LLY | -9.22% | -2.71% | base | -0.17% | +0.45% | -2.64% | -4.04% |
| JNJ | -0.68% | +1.70% | base | -1.63% | +2.13% | +0.67% | +2.13% |
| PFE | -3.00% | -2.47% | base | -2.38% | +0.26% | -2.70% | -4.31% |
| MRK | -4.45% | -1.43% | base | -2.55% | +1.29% | -0.75% | -1.14% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0001628280-26-069106 Size: 3 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 3 Nov 2026: Rhythm Pharmaceuticals (RYTM) versus the S&P 500
Since the first closing price after “8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer),” Rhythm Pharmaceuticals (RYTM) is +8.43%.
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | that day | -1.63% | final price |
| JNJ | the next day | +2.13% | final price |
| JNJ | two days later | +0.67% | final price |
| JNJ | three days later | +2.13% | final price |
| JNJ | three days earlier | +1.70% | final price |
| JNJ | five days earlier | -0.68% | final price |
| LLY | that day | -0.17% | final price |
| LLY | the next day | +0.45% | final price |
| LLY | two days later | -2.64% | final price |
| LLY | three days later | -4.04% | final price |
| LLY | three days earlier | -2.71% | final price |
| LLY | five days earlier | -9.22% | final price |
| MRK | that day | -2.55% | final price |
| MRK | the next day | +1.29% | final price |
| MRK | two days later | -0.75% | final price |
| MRK | three days later | -1.14% | final price |
| MRK | three days earlier | -1.43% | final price |
| MRK | five days earlier | -4.45% | final price |
| PFE | that day | -2.38% | final price |
| PFE | the next day | +0.26% | final price |
| PFE | two days later | -2.70% | final price |
| PFE | three days later | -4.31% | final price |
| PFE | three days earlier | -2.47% | final price |
| PFE | five days earlier | -3.00% | final price |
| Rhythm Pharmaceuticals (RYTM) | that day | -7.76% | final price |
| Rhythm Pharmaceuticals (RYTM) | the next day | +12.35% | final price |
| Rhythm Pharmaceuticals (RYTM) | two days later | +12.37% | final price |
| Rhythm Pharmaceuticals (RYTM) | three days later | +19.95% | final price |
| Rhythm Pharmaceuticals (RYTM) | three days earlier | -0.46% | final price |
| Rhythm Pharmaceuticals (RYTM) | five days earlier | -1.45% | final price |
| XBI | that day | +1.89% | final price |
| XBI | the next day | +4.64% | final price |
| XBI | two days later | -2.40% | final price |
| XBI | three days later | +0.10% | final price |
| XBI | three days earlier | +3.78% | final price |
| XBI | five days earlier | +1.84% | final price |
| XLV | that day | -0.34% | final price |
| XLV | the next day | +2.73% | final price |
| XLV | two days later | +0.31% | final price |
| XLV | three days later | +0.13% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 27 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 34 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 74 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 76 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)”
Companies carried with this story
- RYTM Rhythm Pharmaceuticals
In “8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer),” Rhythm Pharmaceuticals (RYTM) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RYTM
How “8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)” reaches Rhythm Pharmaceuticals (RYTM)
“8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)” (3 Nov 2026) reaches Rhythm Pharmaceuticals (RYTM) through this story.
What ties Rhythm Pharmaceuticals (RYTM) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> RYTM
The price range for Rhythm Pharmaceuticals (RYTM), and the dates in the story
RYTM traded between 81.85 and 115.00 across 6 sessions. The latest close on file is 114.01.
A simple score for Rhythm Pharmaceuticals (RYTM)
14 out of 100
“8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.